Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Taliglucerase_alfa> ?p ?o }
Showing triples 1 to 69 of
69
with 100 triples per page.
- Taliglucerase_alfa abstract "Taliglucerase alfa, commercially known as Elelyso, is a biopharmaceutical drug developed by Protalix and Pfizer. The drug, a recombinant glucocerebrosidase used to treat Gaucher’s Disease, was the first plant-made pharmaceutical to win approval by the U.S. Food and Drug Administration.".
- Taliglucerase_alfa atcPrefix "A16".
- Taliglucerase_alfa atcSuffix "AB11".
- Taliglucerase_alfa casNumber "37228-64-1".
- Taliglucerase_alfa drugbank "DB08876".
- Taliglucerase_alfa fdaUniiCode "0R4NLX88O4".
- Taliglucerase_alfa wikiPageID "30776869".
- Taliglucerase_alfa wikiPageLength "3941".
- Taliglucerase_alfa wikiPageOutDegree "10".
- Taliglucerase_alfa wikiPageRevisionID "701371697".
- Taliglucerase_alfa wikiPageWikiLink Biopharmaceutical.
- Taliglucerase_alfa wikiPageWikiLink Category:EC_3.2.1.
- Taliglucerase_alfa wikiPageWikiLink Category:Israeli_inventions.
- Taliglucerase_alfa wikiPageWikiLink Food_and_Drug_Administration.
- Taliglucerase_alfa wikiPageWikiLink Gauchers_disease.
- Taliglucerase_alfa wikiPageWikiLink Glucocerebrosidase.
- Taliglucerase_alfa wikiPageWikiLink List_of_Israeli_inventions_and_discoveries.
- Taliglucerase_alfa wikiPageWikiLink Pfizer.
- Taliglucerase_alfa wikiPageWikiLink Pharming_(genetics).
- Taliglucerase_alfa wikiPageWikiLink Protalix_BioTherapeutics.
- Taliglucerase_alfa wikiPageWikiLinkText "Elelyso".
- Taliglucerase_alfa wikiPageWikiLinkText "Taliglucerase alfa".
- Taliglucerase_alfa wikiPageWikiLinkText "taliglucerase alfa".
- Taliglucerase_alfa atcPrefix "A16".
- Taliglucerase_alfa atcSuffix "AB11".
- Taliglucerase_alfa c "2580".
- Taliglucerase_alfa casNumber "37228".
- Taliglucerase_alfa chembl "1964120".
- Taliglucerase_alfa chemspiderid "none".
- Taliglucerase_alfa drugbank "DB08876".
- Taliglucerase_alfa eliminationHalfLife "-1722.0".
- Taliglucerase_alfa h "3918".
- Taliglucerase_alfa kegg "D09675".
- Taliglucerase_alfa legalStatus "Rx-only".
- Taliglucerase_alfa molecularWeight "56637.9397".
- Taliglucerase_alfa n "680".
- Taliglucerase_alfa o "727".
- Taliglucerase_alfa routesOfAdministration "Intravenous infusion".
- Taliglucerase_alfa s "17".
- Taliglucerase_alfa tradename "Elelyso / Uplyso".
- Taliglucerase_alfa unii "0".
- Taliglucerase_alfa wikiPageUsesTemplate Template:Drugbox.
- Taliglucerase_alfa wikiPageUsesTemplate Template:Drugs.com.
- Taliglucerase_alfa wikiPageUsesTemplate Template:Enzymes.
- Taliglucerase_alfa wikiPageUsesTemplate Template:Gastrointestinal-drug-stub.
- Taliglucerase_alfa wikiPageUsesTemplate Template:Other_alimentary_tract_and_metabolism_products.
- Taliglucerase_alfa wikiPageUsesTemplate Template:Portal_bar.
- Taliglucerase_alfa wikiPageUsesTemplate Template:Reflist.
- Taliglucerase_alfa wikiPageUsesTemplate Template:Sugar_hydrolases.
- Taliglucerase_alfa subject Category:EC_3.2.1.
- Taliglucerase_alfa subject Category:Israeli_inventions.
- Taliglucerase_alfa hypernym Drug.
- Taliglucerase_alfa type ChemicalSubstance.
- Taliglucerase_alfa type Drug.
- Taliglucerase_alfa type Chemical.
- Taliglucerase_alfa type Drug.
- Taliglucerase_alfa type Redirect.
- Taliglucerase_alfa type ChemicalObject.
- Taliglucerase_alfa type Thing.
- Taliglucerase_alfa type Q8386.
- Taliglucerase_alfa comment "Taliglucerase alfa, commercially known as Elelyso, is a biopharmaceutical drug developed by Protalix and Pfizer. The drug, a recombinant glucocerebrosidase used to treat Gaucher’s Disease, was the first plant-made pharmaceutical to win approval by the U.S. Food and Drug Administration.".
- Taliglucerase_alfa label "Taliglucerase alfa".
- Taliglucerase_alfa sameAs Q7679506.
- Taliglucerase_alfa sameAs m.0gfgymz.
- Taliglucerase_alfa sameAs Taligluceraza_alfa.
- Taliglucerase_alfa sameAs Taligluceraza_alfa.
- Taliglucerase_alfa sameAs Q7679506.
- Taliglucerase_alfa wasDerivedFrom Taliglucerase_alfa?oldid=701371697.
- Taliglucerase_alfa isPrimaryTopicOf Taliglucerase_alfa.